APA (7th ed.) Citation

N, N., A, B., K, C., K, C., AL, D., AY, K., . . . RT, G. (2026). 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 81(Suppl 3), i13. https://doi.org/10.1093/cid/ciaf235

Chicago Style (17th ed.) Citation

N, Nadig, et al. "2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 81, no. Suppl 3 (2026): i13. https://doi.org/10.1093/cid/ciaf235.

MLA (9th ed.) Citation

N, Nadig, et al. "2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 81, no. Suppl 3, 2026, p. i13, https://doi.org/10.1093/cid/ciaf235.